Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04239092
Title 9-ING-41 in Pediatric Patients With Refractory Malignancies.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Actuate Therapeutics Inc.
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.